NIVF Company Profile and Key Details

NIVF has shown weak momentum, losing -24.16% over the past week and -92.84% over the past quarter, though year-to-date performance is down -36.22%. Short-term trend indicators are bullishly aligned (SMA20 -16.38%, SMA50 -49.77%, SMA200 -98.12%). The stock’s 14-day RSI is 32.27 (weak momentum), while the ATR of 0.2 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -99.96% below its high and over 15.01% above its low. Average 10-day trading volume of 99.06 thousand shares is below the 3-month average of 572.52 thousand, indicating normal recent market interest.

NewGenIvf Group Limited has 1.83 million shares outstanding. The public float is 22.54 thousand shares, elevated short interest at 5.67% of float. This equals 103.64 thousand shares. The short ratio is 0.15 days. Institutional investors hold 0.3% of the float. Insiders own 1.05%.

NewGenIvf Group Limited last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.92. This means the shares are trading below this model’s fair value.

NewGenIvf Group Limited (NASDAQ:NIVF) closed at $0.48 USD, losing -$0.11 (-18.08%) from the previous close of $0.59. The stock is currently trading near its 52-week low $0.48 and $1.11 thousand. With a market capitalization of about $11.81 thousand, NewGenIvf Group Limited is classified as a micro-cap and shows lower-than-market volatility (beta ~0.00). Key stats such as the average daily volume over the past year has been around 637.77 thousand shares, volume is running light vs its 52-week average. Headquartered in Bangkok, None, NewGenIvf Group Limited operates in the Healthcare sector and the Medical - Healthcare Plans industry. Led by CEO Wing Fung Siu, the company employs approximately 76 people and listed since March 18, 2022. NewGenIVF Group Ltd. operates as an assisted reproductive services provider.

NewGenIvf Group Limited trades at a P/E ratio of 0.0, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 The P/FCF stands at -0.0, also above market averages.

NewGenIvf Group Limited (NASDAQ:NIVF) shares are down -36.22% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows NewGenIvf Group Limited trading at a premium to the broader market with a P/E of 0.0. Our AI forecast model points to short-term weakness (-62.85% over two weeks), a medium-term fall (-100.0% over three months), and a longer-term loss (-62.85% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that NewGenIvf Group Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -62.85%, with price expected at $0.18 by March 20, 2026, within a range of $0.01 to $0.35 3-Month Outlook: Projected fall of -100.0%, reaching $0.00 by June 04, 2026, with a range of $0.00 to $202.35. 1-Year Outlook: Projected loss of -62.85%, with price at $0.18 by March 05, 2027, within a range of $0.00 to $1.83 thousand.